Literature DB >> 21876175

Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes.

Daniel E Speiser1, Sébastien Wieckowski, Bhawna Gupta, Emanuela M Iancu, Petra Baumgaertner, Lukas Baitsch, Olivier Michielin, Pedro Romero, Nathalie Rufer.   

Abstract

Immune protection from infectious diseases and cancer is mediated by individual T cells of different clonal origin. Their functions are tightly regulated but not yet fully characterized. Understanding the contribution of each T cell will improve the prediction of immune protection based on laboratory assessment of T-cell responses. Here we developed techniques for simultaneous molecular and functional assessment of single CD8 T cells directly ex vivo. We studied two groups of patients with melanoma after vaccination with two closely related tumor antigenic peptides. Vaccination induced T cells with strong memory and effector functions, as found in virtually all T cells of the first patient group, and fractions of T cells in the second group. Interestingly, high functionality was not restricted to dominant clonotypes. Rather, dominant and nondominant clonotypes acquired equal functional competence. In parallel, this was also found for EBV- and CMV-specific T cells. Thus, the nondominant clonotypes may contribute similarly to immunity as their dominant counterparts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21876175      PMCID: PMC3174610          DOI: 10.1073/pnas.1105419108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.

Authors:  Ilhem Messaoudi; Jose A Guevara Patiño; Ruben Dyall; Joël LeMaoult; Janko Nikolich-Zugich
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

2.  A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

Authors:  Daniel E Speiser; Petra Baumgaertner; Catherine Barbey; Verena Rubio-Godoy; Alexandre Moulin; Patricia Corthesy; Estelle Devevre; Pierre-Yves Dietrich; Donata Rimoldi; Danielle Liénard; Jean-Charles Cerottini; Pedro Romero; Nathalie Rufer
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

3.  Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines.

Authors:  Lukas Flatz; Rahul Roychoudhuri; Mitsuo Honda; Abdelali Filali-Mouhim; Jean-Philippe Goulet; Nadia Kettaf; Min Lin; Mario Roederer; Elias K Haddad; Rafick P Sékaly; Gary J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

4.  Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

Authors:  D Valmori; J F Fonteneau; C M Lizana; N Gervois; D Liénard; D Rimoldi; V Jongeneel; F Jotereau; J C Cerottini; P Romero
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

Review 5.  Molecular tracking of antigen-specific T-cell clones during immune responses.

Authors:  Nathalie Rufer
Journal:  Curr Opin Immunol       Date:  2005-08       Impact factor: 7.486

6.  Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

Authors:  Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

7.  Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

Authors:  Daniel E Speiser; Danielle Liénard; Nathalie Rufer; Verena Rubio-Godoy; Donata Rimoldi; Ferdy Lejeune; Arthur M Krieg; Jean-Charles Cerottini; Pedro Romero
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 8.  Human T cell responses against melanoma.

Authors:  Thierry Boon; Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

9.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

10.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.

Authors:  David A Price; Jason M Brenchley; Laura E Ruff; Michael R Betts; Brenna J Hill; Mario Roederer; Richard A Koup; Steven A Migueles; Emma Gostick; Linda Wooldridge; Andrew K Sewell; Mark Connors; Daniel C Douek
Journal:  J Exp Med       Date:  2005-11-14       Impact factor: 14.307

View more
  11 in total

1.  TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Authors:  Mathilde Allard; Barbara Couturaud; Laura Carretero-Iglesia; Minh Ngoc Duong; Julien Schmidt; Gwennaëlle C Monnot; Pedro Romero; Daniel E Speiser; Michael Hebeisen; Nathalie Rufer
Journal:  JCI Insight       Date:  2017-07-20

2.  CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection.

Authors:  Sharvan Sehrawat; Oktay Kirak; Paul-Albert Koenig; Marisa K Isaacson; Sofia Marques; Gunes Bozkurt; J Pedro Simas; Rudolph Jaenisch; Hidde L Ploegh
Journal:  Cell Rep       Date:  2012-04-26       Impact factor: 9.423

3.  Molecular insights for optimizing T cell receptor specificity against cancer.

Authors:  Michael Hebeisen; Susanne G Oberle; Danilo Presotto; Daniel E Speiser; Dietmar Zehn; Nathalie Rufer
Journal:  Front Immunol       Date:  2013-06-19       Impact factor: 7.561

4.  Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.

Authors:  Emanuela M Iancu; Philippe O Gannon; Julien Laurent; Bhawna Gupta; Pedro Romero; Olivier Michielin; Emanuela Romano; Daniel E Speiser; Nathalie Rufer
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

5.  Direct recognition of LPS drive TLR4 expressing CD8+ T cell activation in patients with rheumatoid arthritis.

Authors:  Archana Tripathy; Shweta Khanna; Prasanta Padhan; Shuchi Smita; Sunil Raghav; Bhawna Gupta
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

6.  Trial watch: Peptide vaccines in cancer therapy.

Authors:  Erika Vacchelli; Isabelle Martins; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

Review 7.  Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.

Authors:  Michael Hebeisen; Mathilde Allard; Philippe O Gannon; Julien Schmidt; Daniel E Speiser; Nathalie Rufer
Journal:  Front Immunol       Date:  2015-11-18       Impact factor: 7.561

8.  Heterogeneity assessment of functional T cell avidity.

Authors:  Kalliopi Ioannidou; Petra Baumgaertner; Philippe O Gannon; Michel F Speiser; Mathilde Allard; Michael Hebeisen; Nathalie Rufer; Daniel E Speiser
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

9.  High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.

Authors:  Laura Carretero-Iglesia; Barbara Couturaud; Petra Baumgaertner; Julien Schmidt; Hélène Maby-El Hajjami; Daniel E Speiser; Michael Hebeisen; Nathalie Rufer
Journal:  Front Immunol       Date:  2020-01-08       Impact factor: 7.561

10.  LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures.

Authors:  Nicolas Gestermann; Damien Saugy; Christophe Martignier; Laure Tillé; Silvia A Fuertes Marraco; Markus Zettl; Iñigo Tirapu; Daniel E Speiser; Grégory Verdeil
Journal:  Oncoimmunology       Date:  2020-03-12       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.